Search results
Q1 2024 Vir Biotechnology Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 20 hours agoCarey Hwang I'll begin by reminding you about the initial results from our Phase two psoriasis trial on hepatitis Delta, which was shared at a late-breaker presentation at ...
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
CNBC· 3 days agoSales of AbbVie's Humira are plummeting as the once-top-selling drug fights competition from cheaper...
Vir Biotechnology Inc (VIR) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
GuruFocus.com via Yahoo Finance· 22 hours agoThe company received positive initial data from its Phase 2 psoriasis trial on hepatitis Delta, with significant virologic response rates observed. Vir Biotechnology Inc ( ...
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes· 2 days agoAs of March, the blockbuster autoimmune drug Humira (adalimumab) still held 96% of the market share...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...
Morningstar· 6 days agoPomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...
Change Eligibility Rules for More Diverse Clinical Trials?
Medscape· 1 day agoExpanding eligibility criteria is a strategy for improving the inclusion of traditionally...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 2 days agoBMS strengthened its neuroscience portfolio with the acquisition of Karuna Therapeutics, and its lead asset, KarXT (trospium chloride + xanomeline), a...
Tapinarof Cream for Adult, Pediatric Eczema Under FDA Review
Medscape· 4 days agoA decision on approval is expected in the fourth quarter of 2024.
Children With Chronic Skin Disorders Face Substantial Stigma
Medscape· 5 days agoHealthcare professionals should be aware of the possibility of stigmatization and bullying when...
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit...
Morningstar· 4 days agoThe Law Offices of Frank R. Cruz reminds investors of the upcoming April 30, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Ventyx ...
